MTOR and breast carcinoma: We also examined an Akt-signaling pathway in SCLC cells since the PI3K/AKT/mTOR pathway is frequently activated in SCLC tumors [24] and exogenous introduction of FOXM1 activates the AKT pathway in breast cancer cells [25].